German Company in $3.9 Billion Deal to Buy US Biotech Firm SpringWorks

shared a link

2025-04-28 23:00:09

Merck will acquire SpringWorks Therapeutics for $3.9 billion, aiming to strengthen its U.S. health care presence and expand rare tumor therapies worldwide.Merck KGaA, a German science and technology company,…

0 Comments 0 Shares